See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Gilmartin Capital invests in entrepreneurs targeting platforms that influence large or underserved diseases, technologies that accelerate and expand scientific discovery, and solutions that impact the cost, site and delivery of care. The firm focuses on opportunities that are beyond proof of concept and poised for more significant development and growth in the Medical Device, Life Science Tool, Diagnostic and Digital Health sectors. The investing landscape is long on capital and short on insight. Gilmartin Capital's value extends beyond capital, possessing extensive domain expertise in areas such as strategy, market assessment, and capital markets advisory. The firm has amassed a proprietary expert network consisting of key opinion leaders across multiple therapeutic verticals and technical specialties, and best-in-class operators in various operational, scientific, and financial areas. The majority of fund capital comes from operators, executives, and scientific thought leaders from the healthcare industry.
Notable quotes
“The launch of Gilmartin Capital is the culmination of my passion for healthcare technology and decades of experience as an analyst. I am enthusiastic that our first close is meaningfully oversubscribed with a limited partner group comprised predominantly of executives, operators and scientific thought leaders spanning the healthcare sector. Our strategy is to avail our experience and network to help innovators solve problems, drive scientific discovery, help patients and generate outsized returns for our investors.”
“We have closely followed Galvanize for years and are impressed by its technology, strong team, and execution. Partnering again with Doug after our Shockwave success, and working with such a powerful syndicate, was an opportunity we couldn't refuse. We believe Galvanize's PEF program could significantly improve treatment and benefit patients with serious unmet needs.”
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Galvanize Therapeutics | Series C | $100m | 2025-09-03 |
| SetPoint Medical | Series D | $140m | 2025-08-11 |
| Shoulder Innovations | Public | — | 2025-03-06 |
| Alleviant Medical | Series C | — | 2024-12-19 |
| Kestra Medical Technologies | Public | — | 2024-07-24 |
| Insightec | Series G | — | 2024-06-18 |
Frequent co-investors
Fit check
Is Gilmartin Capital LLC a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit